Ansa Biotechnologies
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1198 65th St Ste 250, Emeryville, Califo...Phone Number
(248) 227-5556Website
www.ansabio.comRevenue
$10.6 MillionIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
2
1
1
1
2
About Ansa Biotechnologies
Ansa Biotechnologies, were developing a way to synthesize DNA that will accelerate innovation in medicine, agriculture, and industrial biotechnology. Our fast, clean, and accurate enzymatic DNA synthesis process can produce gene-length molecules directly, overcoming bottlenecks of traditional DNA synthesis methods. We envision a future where our technology empowers scientists to develop solutions for the world's biggest problems in health and sustainability.Explore more
Ansa Biotechnologies Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ansa Biotechnologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Ansa Biotechnologies
Click to see if Ansa Biotechnologies had a recent Job posting/layoffs
Check if Ansa Biotechnologies has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Ansa Biotechnologies launches new products
Ansa Biotechnologies, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Ansa Biotechnologies recently announced quarterly report
Check out if Ansa Biotechnologies is spiking on competitors!
Funding: Get notified immidiatlly once Ansa Biotechnologies has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Ansa Biotechnologies
Compare insights from companies similar to Ansa Biotechnologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Ansa Biotechnologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Ansa Biotechnologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ansa Biotechnologies.
Ansa Biotechnologies financials insights
Gather financial insights about Ansa Biotechnologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Other Financing Round
$9.2M
Angel/Seed
$7.9M
2022
Series A
$68M
2025
Private Equity
$45.2M
Series B
$54.4M
Ansa Biotechnologies Tech Stack
A closer look at the technologies used by Ansa Biotechnologies
Most Recent Scoops
Hiring Plans
Ansa Biotechnologies has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Open Position
Open Position
Event
Product Marketing, Events, Sales, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Hiring Plans
Hiring Plans
Ansa Biotechnologies News & Media
Ansa Biotechnologies Appoints Geoff Hamilton as Chief Financial Officer and Chief Business Officer
EMERYVILLE, Calif., December 09, 2025--Ansa Biotechnologies announced the appointment of Geoff Hamilton as Chief Financial Officer and Chief Business Officer.Ansa Biotechnologies Secures $54.4 Million in Series B Financing to Redefine How ... - SynBioBeta
Ansa Biotechnologies has successfully raised $54.4 million to enhance its DNA synthesis capabilities, promising unprecedented reliability and innovation for scientists.Ansa Biotechnologies Breaks Traditional Synthetic DNA Length Barriers and Redefines Future of Life Science Research
EMERYVILLE, Calif.--(BUSINESS WIRE)-- #AnsaOnTimeGuarantee--Ansa Biotechnologies launches 50 kb DNA synthesis early access program.Ansa Biotechnologies Sets New Standard in Long, Complex DNA
EMERYVILLE, Calif.--(BUSINESS WIRE)-- #ClonalDNA--Ansa Biotechnologies can now deliver its Ansa Clonal DNA product in lengths up to 5 kb.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Ansa Biotechnologies
Sign Up For FreeTo access detailed company insights
Ansa Biotechnologies, were developing a way to synthesize DNA that will accelerate innovation in medicine, agriculture, and industrial biotechnology. Our fast, clean, and accurate enzymatic DNA synthesis process can produce gene-length molecules directly, overcoming bottlenecks of traditional DNA synthesis methods. We envision a future where our te... Read More
